Corvus Pharmaceuticals, Inc. (CRVS) is currently at $4.24, up $0.89 or 26.57%
--Would be highest close since March 24, 2025, when it closed at $4.25
--On pace for largest percent increase since May 17, 2023, when it rose 36.71%
--Currently up two consecutive days; up 32.5% over this period
--Best two day stretch since the two days ending May 18, 2023, when it rose 37.13%
--Up 18.11% month-to-date
--Down 20.75% year-to-date
--Down 80.16% from its all-time closing high of $21.37 on March 27, 2017
--Up 103.85% from 52 weeks ago (May 10, 2024), when it closed at $2.08
--Down 55.65% from its 52-week closing high of $9.56 on Nov. 11, 2024
--Up 138.2% from its 52-week closing low of $1.78 on July 3, 2024
--Traded as high as $4.38; highest intraday level since March 25, 2025, when it hit $4.38
--Up 30.74% at today's intraday high; largest intraday percent increase since May 17, 2023, when it rose as much as 38.82%
All data as of 11:26:31 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 09, 2025 11:30 ET (15:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.